Patents by Inventor Bernard Teisseire

Bernard Teisseire has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of accelerating the proliferation of emdothelial cells with inhibition of no synthases
    Patent number: 5478821
    Abstract: A method of accelerating the proliferation of endothelial cells with inhibition of NO synthases in warm-blooded animals comprising administering to warm-blooded animals an amount of at least one compound selected from the group consisting of a .beta.-naphthoquinone of the formula ##STR1## wherein R is selected from the group consisting of --NH--CO--NH.sub.2, --NH--C0--CH.sub.3 and --0H and their non-toxic, pharmaceutically acceptable acid addition salts in an amount sufficient to accelerate the proliferation of endothelial cells.
    Type: Grant
    Filed: June 30, 1994
    Date of Patent: December 26, 1995
    Assignee: Roussel UCLAF
    Inventors: Christian Bloy, Jean-Pierre Cazenave, Bernard Hercelin, Bernard Teisseire
  • 2-azabicyclo(2,2,2)octane-3-carboxylic acid derivatives for the treatment of disorders of the cerebral circulation
    Patent number: 5084452
    Abstract: Use of 2-azabicyclo[2.2.2]octane-3-carboxylic acid derivatives and their salts for the production of medicinal products intended for the treatment of arteritis and more especially arteritis of the lower limbs, disorders of the cerebral circulation and more especially disorders of cerebral senescence and migraine, and disorders of vision such as retinal disorders of vascular origin, diabetic retinopathy, chorioretinal atrophy and chorioretinal degeneration.
    Type: Grant
    Filed: April 24, 1990
    Date of Patent: January 28, 1992
    Assignee: Adir et Compagnie
    Inventor: Bernard Teisseire
  • Use of 2-azabicyclo[2.2.2]octane-3-carboxylic acid derivatives for the treatment of migraine
    Patent number: 5036076
    Abstract: Use of 2-azabicyclo[2.2.2]octane-3-carboxylic acid derivatives and their salts for the production of medicinal products intended for the treatment of arteritis and more especially arteritis of the lower limbs, disorders of the cerebral circulation and more especially disorders of cerebral senescence and migraine, and disorders of vision such as retinal disorders of vascular origin, diabetic retinopathy, chorioretinal atrophy and chorioretinal degeneration.
    Type: Grant
    Filed: April 24, 1990
    Date of Patent: July 30, 1991
    Assignee: Adir et Compagnie
    Inventor: Bernard Teisseire
  • Use of 2-azabicycloi[2.2.2]octane-3-carboxylic acid derivatives for the treatment of arteritis
    Patent number: 5021425
    Abstract: Use of 2-azabicyclo[2.2.2.]octane-3-carboxylic acid derivatives and their salts for the treatment of arteritis and more especially arteritis of the lower limbs, disorders of the cerebral circulation and more especially disorders of cerebral senescence and migraine, and disorders of vision such as retinal disorders of vascular origin, diabetic retinopathy, chorioretinal atrophy and chorioretinal degeneration.
    Type: Grant
    Filed: August 22, 1989
    Date of Patent: June 4, 1991
    Assignee: Adir et Compagnie
    Inventor: Bernard Teisseire